Certara (CERT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Executive summary
Annual meeting scheduled for May 14, 2026, at 9:00 a.m. Eastern Time, to be held virtually.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 annual meeting: Arjun Bedi, Stephen McLean, and Jon Resnick.
Ratification of RSM US LLP as the independent registered public accounting firm for 2026.
Advisory vote on executive compensation for the most recently completed fiscal year.
Provision for other business to be transacted as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and auditor ratification.
Latest events from Certara
- FY 2025 revenue rose 9% to $418.8M; 2026 outlook is flat to 4% growth with a new CEO.CERT
Q4 20259 Apr 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting topics.CERT
Proxy filing3 Apr 2026 - AI-driven product launches and disciplined cost control set the stage for cautious 2026 growth.CERT
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - 2026 guidance reflects stable markets, strong biosimulation growth, and operational transformation.CERT
Leerink Global Healthcare Conference 20269 Mar 2026 - Operational rigor, AI innovation, and cloud migration drive growth amid evolving regulatory and market dynamics.CERT
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong biotech demand, AI-driven innovation, and cloud adoption fuel growth amid regulatory shifts.CERT
Stephens Annual Investment Conference3 Feb 2026 - Q2 revenue up 3% to $93.3M, net loss $12.6M, guidance reiterated at $385M–$400M.CERT
Q2 20242 Feb 2026 - Biosimulation and AI adoption accelerate, supported by acquisitions and a unified cloud platform.CERT
Jefferies Global Healthcare Conference1 Feb 2026 - AI-driven software growth and stable services underpin a broad biosimulation market opportunity.CERT
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026